CAS No.:2646-17-5

TOXICITY DATA with REFERENCE：

1.		mmo-sat 2 mg/plate		EMMUEG    Environmental and Molecular Mutagenesis. 19 (Suppl 21)(1992),2.
2.		orl-rat LDLo:5000 mg/kg		JAMAAP    JAMA, Journal of the American Medical Association. 109 (1937),493.
3.		ivn-dog LDLo:200 mg/kg		JAMAAP    JAMA, Journal of the American Medical Association. 109 (1937),493.
4.		orl-rbt LDLo:5000 mg/kg		JAMAAP    JAMA, Journal of the American Medical Association. 109 (1937),493.
5.		ivn-rbt LDLo:60 mg/kg		JAMAAP    JAMA, Journal of the American Medical Association. 109 (1937),493.

Consensus Reports：

IARC Cancer Review: Group 2B IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 ,1987,p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 8 ,1975,p. 165.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . Reported in EPA TSCA Inventory. EPA Genetic Toxicology Program.

SAFETY PROFILE：

Confirmed carcinogen with experimental carcinogenic and neoplastigenic data. Poison by intravenous route. Mildly toxic by ingestion. Mutation data reported. When heated to decomposition it emits toxic fumes of NO_x. Used to color cosmetics, varnishes, oils, fats and waxes, petroleum products.Safety information of 1-(O-Tolylazo)-.beta.-naphthol (2646-17-5):
Hazard Codes  Xn
Risk Statements 
40  Limited evidence of a carcinogenic effect
Safety Statements 
36  Wear suitable protective clothing
22  Do not breathe dust
RTECS  QL5425000

Standards and Recommendations：

 

Analytical Methods：